Dr. Pedro Blasco, head of the Urology Department at Valme Hospital and president of the Ibero-American Society of Neurourology and Urogynecology (SINUG), shares his perspective on the evolution of neuromodulation and its growing relevance in the treatment of overactive bladder.
In his presentation, he highlights the value of this therapeutic alternative due to its minimally invasive nature, its application in the office setting, and its ability to offer a more streamlined, comfortable, and accessible care experience for the patient. In his opinion, this represents a particularly significant advancement in addressing a chronic condition that requires effective, sustainable solutions tailored to each clinical profile.
Dr. Blasco also emphasizes that neuromodulation has undergone a remarkable transformation in recent years, evolving from techniques focused on specific nerve roots toward broader approaches aimed at regulating the nervous system. This evolution reinforces its potential to contribute to improving patients’ quality of life and expanding the available therapeutic options. It also emphasizes the importance of continuing to generate clinical evidence through pilot studies and comparative analyses between centers, in order to precisely define the role these innovations should play in the comprehensive management of overactive bladder. In an environment where personalized treatment is increasingly crucial, incorporating new tools is key to continued progress.
